AKT1 and lung cancer: 5-Caffeoylquinic acid, a homology of 3,5-Di-O-caffeoylquinic acid, inhibits invasive activity of lung cancer cells mediated by the inhibition of p70(S6K)-dependent signaling pathway or the inactivation of Akt [20].